Literature DB >> 23330539

Regulation of the cytosolic sulfotransferases by nuclear receptors.

Melissa Runge-Morris1, Thomas A Kocarek, Charles N Falany.   

Abstract

The cytosolic sulfotransferases (SULTs) are a multigene family of enzymes that catalyze the transfer of a sulfonate group from the physiologic sulfate donor, 3'-phosphoadenosine-5'-phosphosulfate, to a nucleophilic substrate to generate a polar product that is more amenable to elimination from the body. As catalysts of both xenobiotic and endogenous metabolism, the SULTs are major points of contact between the external and physiological environments, and modulation of SULT-catalyzed metabolism can not only affect xenobiotic disposition, but it can also alter endogenous metabolic processes. Therefore, it is not surprising that SULT expression is regulated by numerous members of the nuclear receptor (NR) superfamily that function as sensors of xenobiotics as well as endogenous molecules, such as fatty acids, bile acids, and oxysterols. These NRs include the peroxisome proliferator-activated receptors, pregnane X receptor, constitutive androstane receptor, vitamin D receptor, liver X receptors, farnesoid X receptor, retinoid-related orphan receptors, and estrogen-related receptors. This review summarizes current information about NR regulation of SULT expression. Because species differences in SULT subfamily composition and tissue-, sex-, development-, and inducer-dependent regulation are prominent, these differences will be emphasized throughout the review. In addition, because of the central role of the SULTs in cellular physiology, the effect of NR-mediated SULT regulation on physiological and pathophysiological processes will be discussed. Gaps in current knowledge that require further investigation are also highlighted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23330539      PMCID: PMC3831883          DOI: 10.3109/03602532.2012.748794

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  162 in total

1.  Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver.

Authors:  Zhengbo Duanmu; Amy Weckle; Sevasti B Koukouritaki; Ronald N Hines; Josie L Falany; Charles N Falany; Thomas A Kocarek; Melissa Runge-Morris
Journal:  J Pharmacol Exp Ther       Date:  2005-12-09       Impact factor: 4.030

2.  Dehydroepiandrosterone-sulfate inhibits thrombin-induced platelet aggregation.

Authors:  Alessandra Bertoni; Alessandro Rastoldo; Chiara Sarasso; Clara Di Vito; Sara Sampietro; Michela Nalin; Alessandra Bagarotti; Fabiola Sinigaglia
Journal:  Steroids       Date:  2011-12-13       Impact factor: 2.668

3.  The epidermal cholesterol sulfate cycle.

Authors:  E H Epstein; M L Williams; P M Elias
Journal:  J Am Acad Dermatol       Date:  1984-05       Impact factor: 11.527

4.  Liver X receptor agonist downregulates growth hormone signaling in the liver.

Authors:  Fahad Zadjali; Ruyman Santana-Farre; Mercedes Mirecki-Garrido; Ewa Ellis; Gunnar Norstedt; Leandro Fernandez-Perez; Amilcar Flores-Morales
Journal:  Horm Mol Biol Clin Investig       Date:  2011-11-01

5.  Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor.

Authors:  Hai-Lin Fang; Stephen C Strom; Hongbo Cai; Charles N Falany; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Mol Pharmacol       Date:  2005-01-05       Impact factor: 4.436

6.  Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.

Authors:  Min Sun Kim; Judy Shigenaga; Art Moser; Carl Grunfeld; Kenneth R Feingold
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-06-15       Impact factor: 4.310

7.  Deiodination of iodothyronine sulfamates by type I iodothyronine deiodinase of rat liver.

Authors:  M Rutgers; F A Heusdens; T J Visser
Journal:  Endocrinology       Date:  1991-09       Impact factor: 4.736

8.  Purification and characterization of human liver dehydroepiandrosterone sulphotransferase.

Authors:  C N Falany; M E Vazquez; J M Kalb
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

9.  Up-regulation of transporters and enzymes by the vitamin D receptor ligands, 1alpha,25-dihydroxyvitamin D3 and vitamin D analogs, in the Caco-2 cell monolayer.

Authors:  Jianghong Fan; Shanjun Liu; Yimin Du; Jodi Morrison; Robert Shipman; K Sandy Pang
Journal:  J Pharmacol Exp Ther       Date:  2009-05-04       Impact factor: 4.030

10.  Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs.

Authors:  Melissa Runge-Morris; Thomas A Kocarek
Journal:  PPAR Res       Date:  2009-08-10       Impact factor: 4.964

View more
  26 in total

Review 1.  Sulfotransferase genes: regulation by nuclear receptors in response to xeno/endo-biotics.

Authors:  Susumu Kodama; Masahiko Negishi
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

2.  Intratumoral estrogen sulfotransferase induction contributes to the anti-breast cancer effects of the dithiocarbamate derivative TM208.

Authors:  Xi-wei Ji; Guang-ping Chen; Yan Song; Ming Hua; Li-jie Wang; Liang Li; Yin Yuan; Si-yuan Wang; Tian-yan Zhou; Wei Lu
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

Review 3.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

4.  On the Molecular Basis Underlying the Metabolism of Tapentadol Through Sulfation.

Authors:  Ahsan F Bairam; Mohammed I Rasool; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-10       Impact factor: 2.441

5.  Dopamine D1 receptor activation induces dehydroepiandrosterone sulfotransferase (SULT2A1) in HepG2 cells.

Authors:  Jiao-Jiao Xu; Si-Yuan Wang; Ye Chen; Guang-Ping Chen; Zai-Quan Li; Xue-Yan Shao; Liang Li; Wei Lu; Tian-Yan Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

6.  Regulation of human cytosolic sulfotransferases 1C2 and 1C3 by nuclear signaling pathways in LS180 colorectal adenocarcinoma cells.

Authors:  Elizabeth A Rondini; Hailin Fang; Melissa Runge-Morris; Thomas A Kocarek
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

7.  Increased sulfation of bile acids in mice and human subjects with sodium taurocholate cotransporting polypeptide deficiency.

Authors:  Fengfeng Mao; Teng Liu; Xinfeng Hou; Hanqing Zhao; Wenhui He; Cong Li; Zhiyi Jing; Jianhua Sui; Fengchao Wang; Xiaohui Liu; Jun Han; Christoph H Borchers; Jian-She Wang; Wenhui Li
Journal:  J Biol Chem       Date:  2019-06-14       Impact factor: 5.157

Review 8.  Put "gender glasses" on the effects of phenolic compounds on cardiovascular function and diseases.

Authors:  Ilaria Campesi; Maria Marino; Manuela Cipolletti; Annalisa Romani; Flavia Franconi
Journal:  Eur J Nutr       Date:  2018-04-25       Impact factor: 5.614

9.  Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Intermediates of the Cholesterol Biosynthetic Pathway in Primary Cultured Rat Hepatocytes.

Authors:  Elizabeth A Rondini; Asmita Pant; Thomas A Kocarek
Journal:  J Pharmacol Exp Ther       Date:  2015-10-01       Impact factor: 4.030

10.  Developmental Expression of SULT1C4 Transcript Variants in Human Liver: Implications for Discordance Between SULT1C4 mRNA and Protein Levels.

Authors:  Sarah Dubaisi; Hailin Fang; Joseph A Caruso; Roger Gaedigk; Carrie A Vyhlidal; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Drug Metab Dispos       Date:  2020-04-17       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.